Patents by Inventor Kenneth Gary
Kenneth Gary has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12514839Abstract: Embodiments of the disclosure are drawn to an enteral feeding device for hydrolyzing triglycerides in a nutritional formula. The device may include a body housing a chamber, an inlet configured to fluidly couple with a source of nutritional formula, and an outlet configured to fluidly couple with an enteral feeding tube. The device may include a headspace and a plurality of particles contained within the chamber, wherein the lipase is covalently bonded to the plurality of particles. The device may include an inlet filter located between the inlet and the chamber, wherein the inlet filter contains a first plurality of openings, and an outlet filter located between the chamber and the outlet, wherein the outlet filter has a second plurality of openings smaller than the plurality of particles.Type: GrantFiled: January 19, 2024Date of Patent: January 6, 2026Assignee: Alcresta Therapeutics, Inc.Inventors: Robert Gallotto, Greta L. Loring, Kenneth Gary, Edward S. Park, David J. Brown, Willem Robert Klaas Schoevaart, Michiel Christian Alexander van Vliet
-
Publication number: 20240156768Abstract: Embodiments of the disclosure are drawn to an enteral feeding device for hydrolyzing triglycerides in a nutritional formula. The device may include a body housing a chamber, an inlet configured to fluidly couple with a source of nutritional formula, and an outlet configured to fluidly couple with an enteral feeding tube. The device may include a headspace and a plurality of particles contained within the chamber, wherein the lipase is covalently bonded to the plurality of particles. The device may include an inlet filter located between the inlet and the chamber, wherein the inlet filter contains a first plurality of openings, and an outlet filter located between the chamber and the outlet, wherein the outlet filter has a second plurality of openings smaller than the plurality of particles.Type: ApplicationFiled: January 19, 2024Publication date: May 16, 2024Applicant: Alcresta Therapeutics, Inc.Inventors: Robert GALLOTTO, Greta L. LORING, Kenneth GARY, Edward S. PARK, David J. BROWN, Willem Robert Klaas SCHOEVAART, Michiel Christian Alexander van VLIET
-
Patent number: 11944596Abstract: Embodiments of the disclosure are drawn to an enteral feeding device for hydrolyzing triglycerides in a nutritional formula. The device may include a body housing a chamber, an inlet configured to fluidly couple with a source of nutritional formula, and an outlet configured to fluidly couple with an enteral feeding tube. The device may include a headspace and a plurality of particles contained within the chamber, wherein the lipase is covalently bonded to the plurality of particles. The device may include an inlet filter located between the inlet and the chamber, wherein the inlet filter contains a first plurality of openings, and an outlet filter located between the chamber and the outlet, wherein the outlet filter has a second plurality of openings smaller than the plurality of particles.Type: GrantFiled: May 27, 2021Date of Patent: April 2, 2024Assignee: Alcresta Therapeutics, Inc.Inventors: Robert Gallotto, Greta L. Loring, Kenneth Gary, Edward S. Park, David J. Brown, Willem Robert Klaas Schoevaart, Michiel Christian Alexander van Vliet
-
Patent number: 11911357Abstract: Embodiments of the disclosure are drawn to an enteral feeding device for hydrolyzing triglycerides in a nutritional formula. The device may include a body housing a chamber, an inlet configured to fluidly couple with a source of nutritional formula, and an outlet configured to fluidly couple with an enteral feeding tube. The device may include a headspace and a plurality of particles contained within the chamber, wherein the lipase is covalently bonded to the plurality of particles. The device may include an inlet filter located between the inlet and the chamber, wherein the inlet filter contains a first plurality of openings, and an outlet filter located between the chamber and the outlet, wherein the outlet filter has a second plurality of openings smaller than the plurality of particles.Type: GrantFiled: May 27, 2021Date of Patent: February 27, 2024Assignee: Alcresta Therapeutics, Inc.Inventors: Robert Gallotto, Greta L. Loring, Kenneth Gary, Edward S. Park, David J. Brown, Willem Robert Klaas Schoevaart, Michiel Christian Alexander van Vliet
-
Publication number: 20210283085Abstract: Embodiments of the disclosure are drawn to an enteral feeding device for hydrolyzing triglycerides in a nutritional formula. The device may include a body housing a chamber, an inlet configured to fluidly couple with a source of nutritional formula, and an outlet configured to fluidly couple with an enteral feeding tube. The device may include a headspace and a plurality of particles contained within the chamber, wherein the lipase is covalently bonded to the plurality of particles. The device may include an inlet filter located between the inlet and the chamber, wherein the inlet filter contains a first plurality of openings, and an outlet filter located between the chamber and the outlet, wherein the outlet filter has a second plurality of openings smaller than the plurality of particles.Type: ApplicationFiled: May 27, 2021Publication date: September 16, 2021Applicant: Alcresta Therapeutics, Inc.Inventors: Robert GALLOTTO, Greta L. LORING, Kenneth GARY, Edward S. PARK, David J. BROWN, Willem Robert Klaas SCHOEVAART, Michiel Christian Alexander van VLIET
-
Patent number: 11045440Abstract: Embodiments of the disclosure are drawn to an enteral feeding device for hydrolyzing triglycerides in a nutritional formula. The device may include a body housing a chamber, an inlet configured to fluidly couple with a source of nutritional formula, and an outlet configured to fluidly couple with an enteral feeding tube. The device may include a headspace and a plurality of particles contained within the chamber, wherein the lipase is covalently bonded to the plurality of particles. The device may include an inlet filter located between the inlet and the chamber, wherein the inlet filter contains a first plurality of openings, and an outlet filter located between the chamber and the outlet, wherein the outlet filter has a second plurality of openings smaller than the plurality of particles.Type: GrantFiled: February 27, 2019Date of Patent: June 29, 2021Assignee: Alcresta Therapeutics, Inc.Inventors: Robert Gallotto, Greta L. Loring, Kenneth Gary, Edward S. Park, David J. Brown, Willem Robert Klaas Schoevaart, Michiel Christian Alexander van Vliet
-
Publication number: 20190224155Abstract: Embodiments of the disclosure are drawn to an enteral feeding device for hydrolyzing triglycerides in a nutritional formula. The device may include a body housing a chamber, an inlet configured to fluidly couple with a source of nutritional formula, and an outlet configured to fluidly couple with an enteral feeding tube. The device may include a headspace and a plurality of particles contained within the chamber, wherein the lipase is covalently bonded to the plurality of particles. The device may include an inlet filter located between the inlet and the chamber, wherein the inlet filter contains a first plurality of openings, and an outlet filter located between the chamber and the outlet, wherein the outlet filter has a second plurality of openings smaller than the plurality of particles.Type: ApplicationFiled: February 27, 2019Publication date: July 25, 2019Applicant: Alcresta Therapeutics, Inc.Inventors: Robert Gallotto, Greta L. Loring, Kenneth Gary, Edward S. Park, David J. Brown, Willem Robert Klaas Schoevaart, Michiel Christian Alexander van Vliet
-
Patent number: 10258590Abstract: Embodiments of the disclosure are drawn to an enteral feeding device for hydrolyzing triglycerides in a nutritional formula. The device may include a body housing a chamber, an inlet configured to fluidly couple with a source of nutritional formula, and an outlet configured to fluidly couple with an enteral feeding tube. The device may include a headspace and a plurality of particles contained within the chamber, wherein the lipase is covalently bonded to the plurality of particles. The device may include an inlet filter located between the inlet and the chamber, wherein the inlet filter contains a first plurality of openings, and an outlet filter located between the chamber and the outlet, wherein the outlet filter has a second plurality of openings smaller than the plurality of particles.Type: GrantFiled: October 12, 2016Date of Patent: April 16, 2019Assignee: Alcresta Therapeutics, Inc.Inventors: Robert Gallotto, Greta L. Loring, Kenneth Gary, Edward S. Park, David J. Brown, Willem Robert Klaas Schoevaart, Michiel Christian Alexander van Vliet
-
Publication number: 20170238851Abstract: Sensor systems, transdermal analyte monitoring systems (TAMS), and methods of improving analyte detection are described herein. The sensor systems have two working terminals, at least one counter terminal, and optionally one or more reference terminals. The first working terminal measures electrical signals due to an analyte level along with background interferences. The second working terminal measures only background interferences. The transdermal analyte monitoring systems include the sensor system and a computing device. The computing device performs mathematical analysis using an appropriate algorithm on the electrical information provided by the electrodes of the sensor system to obtain an accurate analyte level. Typically, the second electrical signal is subtracted from the first electrical signal to obtain an accurate analyte level in real time.Type: ApplicationFiled: August 26, 2015Publication date: August 24, 2017Inventors: Eric V. Duhamel, Kenneth Gary
-
Publication number: 20170105903Abstract: Embodiments of the disclosure are drawn to an enteral feeding device for hydrolyzing triglycerides in a nutritional formula. The device may include a body housing a chamber, an inlet configured to fluidly couple with a source of nutritional formula, and an outlet configured to fluidly couple with an enteral feeding tube. The device may include a headspace and a plurality of particles contained within the chamber, wherein the lipase is covalently bonded to the plurality of particles. The device may include an inlet filter located between the inlet and the chamber, wherein the inlet filter contains a first plurality of openings, and an outlet filter located between the chamber and the outlet, wherein the outlet filter has a second plurality of openings smaller than the plurality of particles.Type: ApplicationFiled: October 12, 2016Publication date: April 20, 2017Applicant: ALCRESTA THERAPEUTICS, INC.Inventors: Robert GALLOTTO, Greta L. LORING, Kenneth GARY, Edward S. PARK, David J. BROWN, Willem Robert Klaas SCHOEVAART, Michiel Christian Alexander van VLIET
-
Publication number: 20120077277Abstract: Analyte meter protectors, meters that include the same, and methods.Type: ApplicationFiled: December 6, 2011Publication date: March 29, 2012Inventors: Frederic Arbogast, Paul Strasma, Lawrence Azzano, Kenneth Gary
-
Patent number: 8080205Abstract: Analyte meter protectors, meters that include the same, and methods. In one example, a ketone monitoring system is provided wherein a port protector is used in combination with a meter.Type: GrantFiled: February 24, 2011Date of Patent: December 20, 2011Assignee: Abbott Diabetes Care Inc.Inventors: Frederic Arbogast, Paul Strasma, Lawrence Azzano, Kenneth Gary
-
Publication number: 20110253532Abstract: Analyte meter protectors, meters that include the same, and methods.Type: ApplicationFiled: February 24, 2011Publication date: October 20, 2011Inventors: Frederic Arbogast, Paul Strasma, Lawrence Azzano, Kenneth Gary
-
Patent number: 7914742Abstract: Analyte meter protectors, meters that include the same, and methods.Type: GrantFiled: November 20, 2009Date of Patent: March 29, 2011Assignee: Abbott Diabetes Care Inc.Inventors: Frederic Arbogast, Paul Strasma, Lawrence Azzano, Kenneth Gary
-
Patent number: 7897107Abstract: Analyte meter protectors, meters that include the same, and methods.Type: GrantFiled: September 30, 2009Date of Patent: March 1, 2011Assignee: Abbott Diabetes Care Inc.Inventors: Frederic Arbogast, Paul Strasma, Lawrence Azzano, Kenneth Gary
-
Patent number: 7867446Abstract: Analyte meter protectors, meters that include the same, and methods.Type: GrantFiled: September 30, 2009Date of Patent: January 11, 2011Assignee: Abbott Diabetes Care Inc.Inventors: Frederic Arbogast, Paul Strasma, Lawrence Azzano, Kenneth Gary
-
Patent number: 7846388Abstract: Analyte meter protectors, meters that include the same, and methods.Type: GrantFiled: June 30, 2009Date of Patent: December 7, 2010Assignee: Abbott Diabetes Care Inc.Inventors: Frederic Arbogast, Paul Strasma, Lawrence Azzano, Kenneth Gary
-
Patent number: 7846387Abstract: Analyte meter protectors, meters that include the same, and methods.Type: GrantFiled: June 30, 2009Date of Patent: December 7, 2010Assignee: Abbott Diabetes Care Inc.Inventors: Frederic Arbogast, Paul Strasma, Lawrence Azzano, Kenneth Gary
-
Patent number: 7846386Abstract: Analyte meter protectors, meters that include the same, and methods.Type: GrantFiled: June 30, 2009Date of Patent: December 7, 2010Assignee: Abbott Diabetes Care Inc.Inventors: Frederic Arbogast, Paul Strasma, Lawrence Azzano, Kenneth Gary
-
Patent number: 7846385Abstract: Analyte meter protectors, meters that include the same, and methods.Type: GrantFiled: June 30, 2009Date of Patent: December 7, 2010Assignee: Abbott Diabetes Care Inc.Inventors: Frederic Arbogast, Paul Strasma, Lawrence Azzano, Kenneth Gary